Overall, cannabinoids provide modest, condition-specific analgesia and should be considered adjunctive rather than first-line options, reserved for patients unresponsive to conventional therapy.
What Pending Medical Cannabis and Hemp Legislation Means for Georgia | JD Supra
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PolicyHempTHCCBD Why This Matters Georgia's proposed legislation to eliminate the 5% THC cap would allow...
First medical cannabis dispensary opening in Alabama in May – Yahoo
✦ New CED Clinical Relevance #84High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic AccessPolicyState ProgramsChronic PainPtsd Why This MattersAlabama's first medical cannabis dispensary represents expanded patient...
Alabama medical cannabis sales to start in May – MJBizDaily
✦ New CED Clinical Relevance #84High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Medical CannabisState PolicyPatient AccessChronic PainPtsd Why This MattersAlabama becomes the 38th state to...
Full-Spectrum Cannabis Extract Shows Significant Pain Reduction in Chronic Neuropathic Pain
If you live with chronic nerve pain, this study provides clinical evidence that full-spectrum cannabis extracts can deliver meaningful relief with fewer side effects than many conventional pain medications. A clinical study found that a full-spectrum cannabis extract containing a balanced ratio of THC and CBD produced statistically significant reductions in chronic neuropathic pain compared to placebo. Patients reported meaningful improvements in pain intensity, sleep quality, and overall quality of life with minimal adverse effects.